Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
- Resource Type
- Article
- Source
- In
The Lancet Gastroenterology & Hepatology October 2021 6(10):816-825 - Subject
Primary Research Articles - Language
- ISSN
- 2468-1253